Abstract

Six implementation research studies in Malawi, Nigeria, and Zimbabwe tested approaches for improving retention in care among women living with HIV. We simulated the impact of their interventions on the probability of HIV transmission during pregnancy and breastfeeding. A computer-based state-transition model was developed to estimate the impact of the retention interventions. Patient-level data from the 6 studies were aggregated and analyzed, and weighted averages of mother-to-child transmission (MTCT) of HIV probabilities were presented. The average MTCT probability of the more successful interventions was applied to national estimates to calculate potential infections averted if these interventions were taken to scale. Among the total cohort of 5742 HIV-positive women, almost 80% of all infant infections are attributed to the roughly 20% of HIV-positive pregnant and breastfeeding women not retained on antiretroviral therapy. Higher retention in the arms receiving interventions resulted in an overall lower estimated MTCT probability of 9.9% compared with 12.3% in the control arms. In the 2 studies that showed a statistically significant effect, Prevention of MTCT Uptake and Retention (PURE) and Mother Mentor (MoMent), the difference in transmission rates between intervention and control arms was 4.1% and 7.3%, respectively. Scaling up retention interventions nationally in the 3 countries could avert an average of almost 3000 infant infections annually. Linking HIV-positive pregnant women to antiretroviral therapy and retaining them is essential for addressing the remaining gaps and challenges in HIV/AIDS care and the elimination of MTCT. At national level, even modest improvements in retention translates into large numbers of infant infections averted.

Highlights

  • The INSPIRE (Integrating and Scaling up prevention of mother-to-child transmission of HIV (PMTCT) through Implementation REsearch) initiative comprised 6 implementation research studies—2 each in Malawi, Nigeria, and Zimbabwe.[1]

  • Higher retention in the arms receiving interventions resulted in an overall lower estimated mother-tochild transmission (MTCT) probability of 9.9% compared with 12.3% in the control arms

  • We developed the PMTCT and Pediatric Impact and Cost Model in 2010 to inform national health decision making regarding the elimination of MTCT and antiretroviral therapy (ART) scaleup for pregnant women and children, with a focus on countrylevel adoption of the World Health Organization HIV treatment guidelines as they were released and maximizing the impact with available resources, drugs, diagnostics, and health workers.[4,5,6,7]

Read more

Summary

Introduction

The INSPIRE (Integrating and Scaling up PMTCT through Implementation REsearch) initiative comprised 6 implementation research studies—2 each in Malawi, Nigeria, and Zimbabwe.[1]. Clinical trials and programs in developed countries have shown that it is possible to significantly reduce mother-tochild transmission (MTCT) of HIV, putting virtual elimination of MTCT within reach These data inspired the “Global Plan,” an effort across 21 prioritized countries in sub-Saharan Africa and India to achieve a MTCT rate of 5% or less among breastfeeding populations and 2% or less among nonbreastfeeding populations by 2015.2 Significant progress toward this goal has been made, with a reduction from 28% in 2009 to 14% in 2014.3 the operational realities of implementing antiretroviral therapy (ART) programs and. By testing multiple innovations targeting improvements in service delivery and retention for HIV-positive women in 6 different real-world settings, the INSPIRE studies aimed to provide evidence to inform program design that will bring countries close to the goal of achieving virtual elimination of MTCT of HIV. We simulated the impact of their interventions on the probability of HIV transmission during pregnancy and breastfeeding

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call